MedPath

Effect of Probiotics on Periodontitis Stage III Grade C Molar-incisor Pattern

Phase 3
Completed
Conditions
Periodontal Diseases
Interventions
Drug: Probiotic Formula
Drug: placebo formula
Registration Number
NCT06253988
Lead Sponsor
Al-Azhar University
Brief Summary

the research highlight the effectiveness of probiotics as adjuncts to SRP in the treatment of periodontitis stage III grade C molar-incisor pattern

Detailed Description

Background data : Periodontitis is a common disease that represents a public health problem. Aggregatibacter actinomycetemcomitans (A. a ) especially the JP2 genotype plays a major role in the pathogenesis of periodontitis. The aim of this study is to evaluate the effect of topically applied probiotics on the management of periodontitis stage III grade C molar-incisor pattern.

Methods: Sixty-five patients having periodontitis stage III grade C molar-incisor pattern. Screening for A. actinomycetemcomians (A.a) and the JP2 genotype was done using conventional polymerase chain reaction (PCR). Patients positive for (A. a) were randomly divided into two groups. Group I: received conventional periodontal treatment combined with topically applied probiotic, while Group II: received conventional periodontal treatment only. Both groups were evaluated microbiologically and clinically. Quantitative assessment of A. a levels was done by real time PCR (qPCR) at baseline as well as one week, 4 weeks, and 12 weeks after treatment. Clinical parameters were assessed before treatment as well as 3,6 and 9 months after treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • patients have periodontitis stage III grade C molar-incisor pattern .
Exclusion Criteria
  • Pregnant or nursing women,
  • smokers,
  • patients received periodontal therapy,
  • systemic antimicrobials or anti-inflammatory drugs in the last six
  • patients with unacceptable oral hygiene

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group probioticProbiotic Formulareceived conventional periodontal treatment combined with topically applied probiotic
Group placeboplacebo formulareceived conventional periodontal treatment only.
Primary Outcome Measures
NameTimeMethod
quantitative assessment of A. actinomycetemcomians levels by picogramat baseline (before treatment) used by conventional PCR

Microbiological evaluation by picogram

Assessment of clinical periodontal parameter : Probing pocket Depth (PPD) by mmat base line , 1 , 3 , 6 months

Clinical evaluation mm

Assessment of clinical periodontal parameter : Clinical Attachment Level (CAL) by mmat base line , 1 , 3 , 6 months

Clinical evaluation by "mm"

Secondary Outcome Measures
NameTimeMethod
quantitative assessment of A. actinomycetemcomians levels by picogrambaseline ,1 ,3 and 6 months

microbiological by picogram

Trial Locations

Locations (1)

Alazhar university ,faculty of Dental Medicine

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath